AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30357263 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA+AA (200 mg DHA and 200 mg AA daily for 6 months)
Number of subjects: 377
Study 30357263 — intervention group
Group type: COMPARATOR
Intervention: Placebo (microencapsulated corn oil)
Number of subjects: 377
Study 27693978 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture plus fluoxetine (n=22)
Number of subjects: 46
Study 27693978 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture plus fluoxetine (n=24)
Number of subjects: 46
Study 25527480 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at slow speed (100 m)
Number of subjects: 46
Study 25527480 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at medium speed (100 m)
Number of subjects: 46
Study 25527480 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking at fast speed (100 m)
Number of subjects: 46
Study 25527480 — intervention group
Group type: EXPERIMENTAL
Intervention: Awkward carry (13.6 kg)
Number of subjects: 46
Study 25527480 — intervention group
Group type: EXPERIMENTAL
Intervention: Side carry (13.6 kg)
Number of subjects: 46
Study 25527480 — intervention group
Group type: EXPERIMENTAL
Intervention: Front carry (13.6 kg)
Number of subjects: 46
Study 25527480 — intervention group
Group type: COMPARATOR
Intervention: Carry-in-backpack (13.6 kg)
Number of subjects: 46
Study 23949801 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glucose regimen (combination of dextrose-based solution, icodextrin and amino acids)
Number of subjects: 251
Study 23949801 — intervention group
Group type: COMPARATOR
Intervention: Dextrose solutions only (control group)
Number of subjects: 251
Study 23949801 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glucose regimen (intervention group)
Number of subjects: 251
Study 23181643 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 187
Study 23181643 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgency symptoms
Number of subjects: 187
Study 18978606 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based perceptual training (N = 8)
Number of subjects: 16
Study 18978606 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 8)
Number of subjects: 16
Study 18978606 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based perceptual training
Number of subjects: 16
Study 18978606 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study 16142502 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (20 or 40 mcg/day)
Number of subjects: 5
Study 16142502 — intervention group
Group type: COMPARATOR
Intervention: Placebo or antiresorptive drugs (including hormone replacement therapy and alendronate)
Number of subjects: 5
Study 14727367 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antiphlogistic medicinal granules only (Group A)
Number of subjects: 160
Study 14727367 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antiphlogistic medicinal granules + retention enema (Group B)
Number of subjects: 160
Study 14727367 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antiphlogistic medicinal granules + rectal (Group C)
Number of subjects: 160
Study 14727367 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiphlogistic medicinal granules + rectally + hip bath (Group D)
Number of subjects: 160
Study 11527612 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide (two 180 microg/kg boluses 10 min apart and continuous infusion of 2 microg/kg per min)
Number of subjects: 2064
Study 11527612 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2064
Study 11527612 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 2064
Study 9547132 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg once a day, titrated to a maximum of 200 mg)
Number of subjects: 59
Study 9547132 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (2 full years treatment)
Number of subjects: 59
Study 9547132 — intervention group
Group type: COMPARATOR
Intervention: Placebo (during double-blind phase)
Number of subjects: 59
Study 9547132 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (during double-blind phase)
Number of subjects: 59
Study 8420344 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms ethinyl estradiol and 150 micrograms desogestrel (n = 15)
Number of subjects: 34
Study 8420344 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms ethinyl estradiol and 75 micrograms gestodene (n = 19)
Number of subjects: 34
Study 2877884 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine (SASP)
Number of subjects: 9
Study 2877884 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentasa
Number of subjects: 9
Study 31230147 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat peptides and fucoidan (WPF)
Number of subjects: 106
Study 30105816 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling combined with PRP
Number of subjects: 24
Study 30105816 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling combined with TCA 15% peeling
Number of subjects: 24
Study 30105816 — intervention group
Group type: COMPARATOR
Intervention: Microneedling alone
Number of subjects: 24
Study 27194317 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led lymphoma survivorship clinic with three face-to-face appointments and tailored resources, survivorship care plan and treatment summary (SCP TS).
Number of subjects: 0
Study 27194317 — intervention group
Group type: COMPARATOR
Intervention: Usual post-treatment care.
Number of subjects: 0
Study 24326536 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Health Record (PHR)
Number of subjects: 1075
Study 24326536 — intervention group
Group type: EXPERIMENTAL
Intervention: High users of PHR
Number of subjects: 1075
Study 24326536 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1075
Study 24139256 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine hydrochloride with 12.5 μg/mL epinephrine
Number of subjects: 20
Study 24139256 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine hydrochloride
Number of subjects: 20
Study 24139256 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% ethyl aminobenzoate
Number of subjects: 20
Study 24139256 — intervention group
Group type: EXPERIMENTAL
Intervention: physiological saline solution
Number of subjects: 20
Study 24139256 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% ethyl aminobenzoate (cotton ball)
Number of subjects: 20
Study 24139256 — intervention group
Group type: COMPARATOR
Intervention: 30-gauge needle insertion
Number of subjects: 20
Study 24139256 — intervention group
Group type: EXPERIMENTAL
Intervention: 33-gauge needle insertion
Number of subjects: 20
Study 21940510 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose (75 g)
Number of subjects: 16
Study 21940510 — intervention group
Group type: COMPARATOR
Intervention: Fructose (75 g)
Number of subjects: 16
Study 18262151 — intervention group
Group type: COMPARATOR
Intervention: Blind biopsy (Novak's curette)
Number of subjects: 319
Study 18262151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopy
Number of subjects: 319
Study 16618270 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan (10 to 40 mg)
Number of subjects: 24
Study 12795037 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate treatment for progressive MS
Number of subjects: 52
Study 10707514 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia
Number of subjects: 12
Study 10707514 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane anesthesia
Number of subjects: 12
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit superposition during VOR cancellation
Number of subjects: 0
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: VOR response during CW roll with target light on
Number of subjects: 0
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye position change from 20 deg up to 20 deg down during CW roll
Number of subjects: 0
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: VOR response during rightward rotation while looking 20 deg up
Number of subjects: 0
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall eye velocities during cancellation
Number of subjects: 0
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: VOR gain reduction
Number of subjects: 0
Study 8793761 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit driven by retinal slip
Number of subjects: 0
Study 1626732 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline, oral administration at a dose of 1,200 mg daily during healing and 400 mg daily during ulcer-free intervals
Number of subjects: 51
Study 1626732 — intervention group
Group type: COMPARATOR
Intervention: Deferoxamine, intravenous dose of 20 mg/kg
Number of subjects: 51
Study 3890639 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (0.05 mg/kg)
Number of subjects: 6
Study 3890639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31780002 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology (15 min on each foot, total 30 min, twice a week for six weeks)
Number of subjects: 90
Study 31780002 — intervention group
Group type: COMPARATOR
Intervention: Routine care for menopause patients
Number of subjects: 90
Study 28070639 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy carbohydrate diet (HCD) rich in cereal fibre, arabinoxylan and resistant starch
Number of subjects: 19
Study 28070639 — intervention group
Group type: COMPARATOR
Intervention: Refined-carbohydrate western-style diet (WSD)
Number of subjects: 19
Study 30645840 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbs combined DHEA pretreatment for 8 weeks
Number of subjects: 233
Study 30645840 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA pretreatment for 8 weeks
Number of subjects: 233
Study 30645840 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 233
Study 30645840 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbs combined DHEA pretreatment
Number of subjects: 233
Study 30645840 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA pretreatment
Number of subjects: 233
Study 23877142 — intervention group
Group type: EXPERIMENTAL
Intervention: OxyBand dressing
Number of subjects: 20
Study 23877142 — intervention group
Group type: COMPARATOR
Intervention: Xeroform gauze dressing
Number of subjects: 20
Study 23877142 — intervention group
Group type: EXPERIMENTAL
Intervention: OxyBand dressing and Xeroform gauze dressing
Number of subjects: 20
Study 22156855 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment for 8 weeks
Number of subjects: 134
Study 20501774 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention promoting a reduced fat diet
Number of subjects: 230
Study 20501774 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study 18938291 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory intervention before terrorism media exposure
Number of subjects: 80
Study 18938291 — intervention group
Group type: EXPERIMENTAL
Intervention: Terrorism media exposure
Number of subjects: 80
Study 18938291 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 80
Study 18938291 — intervention group
Group type: COMPARATOR
Intervention: Non-terrorism media broadcast
Number of subjects: 80
Study 16860046 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day hormone-free interval (HFI)
Number of subjects: 12
Study 16860046 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day hormone-free interval (HFI)
Number of subjects: 12
Study 16860046 — intervention group
Group type: COMPARATOR
Intervention: 7-day hormone-free interval (HFI)
Number of subjects: 12
Study 12826045 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 200 mg/m2 as a 3-h infusion followed by carboplatin at AUC 6 every 3 weeks for three courses
Number of subjects: 52
Study 12826045 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel/carboplatin induction regimen
Number of subjects: 52
Study 11079666 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol treatment
Number of subjects: 19
Study 11079666 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 8783111 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation without catheter removal
Number of subjects: 17
Study 8783111 — intervention group
Group type: COMPARATOR
Intervention: Anticoagulation with early catheter removal
Number of subjects: 17
Study 1321056 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide (1.6 mg.day‐1 for 7 days)
Number of subjects: 0
Study 1321056 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone (30 mg.day‐1 for 3 days)
Number of subjects: 0
Study 1321056 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose oral dexamethasone (8 mg.day‐1 for 2 days)
Number of subjects: 0
Study 1321056 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro dexamethasone greater than 10(‐8) M
Number of subjects: 0
Study 6148382 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg LI 32-468
Number of subjects: 0
Study 6148382 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg LI 32-468
Number of subjects: 0
Study 6148382 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg LI 32-468
Number of subjects: 0
Study 6148382 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg propranolol
Number of subjects: 0
Study 6148382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31682194 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-Based Treatment in a day hospital setting (MBT-DH)
Number of subjects: 95
Study 31682194 — intervention group
Group type: COMPARATOR
Intervention: Specialist Treatment as Usual (S-TAU)
Number of subjects: 95
Study 30448598 — intervention group
Group type: EXPERIMENTAL
Intervention: Besifovir dipivoxil maleate (BSV) 150 mg
Number of subjects: 197
Study 30448598 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (TDF) 300 mg
Number of subjects: 197
Study 30448598 — intervention group
Group type: EXPERIMENTAL
Intervention: BSV (after switching from TDF)
Number of subjects: 197
Study 30448598 — intervention group
Group type: COMPARATOR
Intervention: TDF (after switching to BSV)
Number of subjects: 197
Study 30448598 — intervention group
Group type: EXPERIMENTAL
Intervention: BSV
Number of subjects: 197
Study 30448598 — intervention group
Group type: COMPARATOR
Intervention: TDF
Number of subjects: 197
Study 30448598 — intervention group
Group type: COMPARATOR
Intervention: BSV and TDF
Number of subjects: 197
Study 28358380 — intervention group
Group type: EXPERIMENTAL
Intervention: Cover sheet added to the permission form (intervention)
Number of subjects: 32
Study 28358380 — intervention group
Group type: COMPARATOR
Intervention: Standard form (control)
Number of subjects: 32
Study 25287163 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium picosulfate with magnesium citrate (SPMC) plus bisacodyl
Number of subjects: 365
Study 25287163 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyethylene glycol (PEG)
Number of subjects: 365
Study 23839751 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein isolate (20 g daily)
Number of subjects: 177
Study 23839751 — intervention group
Group type: COMPARATOR
Intervention: Calcium caseinate (placebo)
Number of subjects: 177
Study 21863389 — intervention group
Group type: EXPERIMENTAL
Intervention: IV‐PCA (n = 30)
Number of subjects: 60
Study 21863389 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 30)
Number of subjects: 60
Study 18645042 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical treatment
Number of subjects: 83
Study 18645042 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment by functional bracing
Number of subjects: 83
Study 16538011 — intervention group
Group type: COMPARATOR
Intervention: Direct stent alone (Group D)
Number of subjects: 77
Study 16538011 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent after RESCUE/Thrombuster system (Group R/T)
Number of subjects: 77
Study 16538011 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent after thrombus suction using a PercuSurge GuardWire catheter (Group P)
Number of subjects: 77
Study 12655619 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (CBT)
Number of subjects: 60
Study 12655619 — intervention group
Group type: COMPARATOR
Intervention: Group cognitive-behavioral therapy (CBT)
Number of subjects: 60
Study 11194948 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-conformal-radiation therapy (3D-CRT)
Number of subjects: 0
Study 11194948 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-conformal-radiation therapy (3D-CRT) with escalated dose (+10 or 15%)
Number of subjects: 0
Study 8690970 — intervention group
Group type: EXPERIMENTAL
Intervention: THELEP‐recommended regimen (600 mg rifampin, 600 mg clofazimine supervised on two consecutive days monthly, 225 mg diacetyl diaminodiphenylsulfone bimonthly, 100 mg dapsone daily unsupervised)
Number of subjects: 1067
Study 8690970 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional MDT (600 mg rifampin, 300 mg clofazimine supervised once a month, 100 mg dapsone daily unsupervised, 50 mg clofazimine daily unsupervised)
Number of subjects: 1067
Study 1599110 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (3.5 micrograms.kg-1 orally)
Number of subjects: 5
Study 6202851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (CPL)
Number of subjects: 158
Study 6202851 — intervention group
Group type: COMPARATOR
Intervention: Bleomycin, cyclophosphamide, and dactinomycin (BCD)
Number of subjects: 158
Study 6202851 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibroblast interferon
Number of subjects: 158
Study 6202851 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDMTX)
Number of subjects: 158
Study 29602994 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical coaching (N=12)
Number of subjects: 24
Study 29602994 — intervention group
Group type: COMPARATOR
Intervention: Control group (N=12)
Number of subjects: 24
Study 29602994 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical coaching
Number of subjects: 24
Study 27075273 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-professional education (IPE) course
Number of subjects: 0
Study 26289764 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-up procedure (Group 1 - first case of the day)
Number of subjects: 82
Study 26289764 — intervention group
Group type: COMPARATOR
Intervention: Post-warm-up procedure (Group 2 - second case of the day)
Number of subjects: 82
Study 24380385 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional dietary modifications
Number of subjects: 33
Study 24380385 — intervention group
Group type: COMPARATOR
Intervention: Weight reduction advice in the form of an Energy Prescription (EP)
Number of subjects: 33
Study 20666814 — intervention group
Group type: EXPERIMENTAL
Intervention: Two presurgical skin pretreatment methods (details not specified)
Number of subjects: 48
Study 20666814 — intervention group
Group type: EXPERIMENTAL
Intervention: Interoperative irrigation with sterile saline solution
Number of subjects: 48
Study 20666814 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenol application after nail removal
Number of subjects: 48
Study 18239197 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg trihexyphenidyl
Number of subjects: 24
Study 18239197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 16603147 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg Fe daily
Number of subjects: 24
Study 16603147 — intervention group
Group type: COMPARATOR
Intervention: 50 mg Fe twice weekly
Number of subjects: 24
Study 12453547 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (2.5 and 5 mg)
Number of subjects: 12
Study 12453547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10511352 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial vaporization
Number of subjects: 91
Study 10511352 — intervention group
Group type: COMPARATOR
Intervention: Resection using standard cutting loop
Number of subjects: 91
Study 7717236 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.6 mg/kg 20-30 min before cystourethrography
Number of subjects: 98
Study 7717236 — intervention group
Group type: COMPARATOR
Intervention: Control group (no midazolam)
Number of subjects: 98
Study 7717236 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.6 mg/kg
Number of subjects: 98
Study 2038109 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg
Number of subjects: 24
Study 2038109 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 7224205 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile anesthesia breathing circuits with bacterial filters
Number of subjects: 293
Study 7224205 — intervention group
Group type: COMPARATOR
Intervention: Reusable circuit that had been washed and dried after previous use (Control)
Number of subjects: 293
Study 7224205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 293
Study 31945548 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT as an adjunct to ultrasonic scaling (US)
Number of subjects: 45
Study 31945548 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM as an adjunct to ultrasonic scaling (US)
Number of subjects: 45
Study 31945548 — intervention group
Group type: COMPARATOR
Intervention: US alone
Number of subjects: 45
Study 31567872 — intervention group
Group type: EXPERIMENTAL
Intervention: Central European diet (CED)
Number of subjects: 100
Study 31567872 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED)
Number of subjects: 100
Study 31567872 — intervention group
Group type: EXPERIMENTAL
Intervention: Central European diet (CED) with minor allele of FADS genes
Number of subjects: 100
Study 27839807 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed remote ischemic preconditioning (RIPC)
Number of subjects: 160
Study 27839807 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 160
Study 25499915 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (n=24)
Number of subjects: 34
Study 25499915 — intervention group
Group type: COMPARATOR
Intervention: No physical activity (n=10)
Number of subjects: 34